STAANasdaqOphthalmic GoodsFiscal year ends January 2
STAAR SURGICAL CO
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 12, 2026
$21.88+0.61 (+2.87%)
Close on Oct 19, 2026
- Market cap
- $1.13B
- P/E (TTM)
- 312.6
- Dividend yield
- –
Staar Surgical statistics
Financials through Jul 3, 2026, price as of Oct 19, 2026, median of Ophthalmic Goods companies for comparison
Valuation
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Market Cap | $1.10B | $230.55M |
| Enterprise Value | $915.66M | $202.97M |
| PE Ratio | 312.57 | 33.40 |
| PS Ratio | 3.23 | 3.11 |
| PB Ratio | 3.00 | 3.14 |
| P/TBV Ratio | 3.02 | 4.57 |
Enterprise value
| Measure | Staar Surgical | Industry median |
|---|---|---|
| EV / Sales | 2.70 | 2.92 |
| EV / EBITDA | 66.68 | 19.86 |
| EV / EBIT | 66.68 | 24.88 |
Income (trailing twelve months)
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Revenue | $339.59M | $102.39M |
| Gross Profit | $260.20M | $60.36M |
| Operating Income | $13.73M | -$4.31M |
| Pretax Income | $17.38M | -$2.26M |
| Net Income | $3.84M | -$6.57M |
| EBITDA | $13.73M | -$1.98M |
| EPS (Diluted) | $0.07 | -$0.07 |
Margins
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Gross Margin | 76.6% | 55.1% |
| Operating Margin | 4.04% | -6.04% |
| Pretax Margin | 5.12% | -4.11% |
| Profit Margin | 1.13% | -10.5% |
| EBITDA Margin | 4.04% | -2.67% |
| FCF Margin | -1.99% | -0.30% |
Returns
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Return on Equity (ROE) | 1.09% | -19.2% |
| Return on Assets (ROA) | 0.84% | -13.3% |
| Return on Invested Capital (ROIC) | 4.15% | -4.11% |
| Return on Capital Employed (ROCE) | 3.42% | -9.07% |
Growth
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 51.3% | 8.85% |
| Revenue Growth (3Y CAGR) | 0.00% | 7.08% |
| Revenue Growth (5Y CAGR) | 7.93% | 11.8% |
Balance sheet
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $181.49M | $37.33M |
| Net Cash (Debt) | $181.49M | $3.92M |
| Net Cash Per Share | $3.62 | $0.28 |
| Equity (Book Value) | $365.40M | $57.36M |
| Book Value Per Share | $7.29 | $2.81 |
| Tangible Book Value | $363.61M | $10.71M |
| Working Capital | $268.96M | $54.64M |
Financial position
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Current Ratio | 4.66 | 2.50 |
| Quick Ratio | 3.81 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Operating Cash Flow | -$3.25M | -$653.46K |
| Capital Expenditures | -$3.50M | -$3.69M |
| Free Cash Flow | -$6.75M | -$835.02K |
| FCF Per Share | -$0.13 | -$0.02 |
Efficiency
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Asset Turnover | 0.74 | 0.59 |
| Revenue Per Employee | $354.85K | $322.57K |
| Profits Per Employee | $4.01K | -$51.88K |
| Employee Count | 957 | 185 |
Dividends and yields
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Earnings Yield | 0.35% | -6.91% |
| FCF Yield | -0.62% | -0.56% |
Shares
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Shares Outstanding | 50,144,000 | 44,856,700 |
| Shares Change (YoY) | 3.30% | 3.35% |
| Shares Change (QoQ) | 0.69% | 0.27% |
| Shares Held by Institutions | 110.1% | 63.5% |
Taxes
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Income Tax | $13.54M | $1.52M |
| Effective Tax Rate | 77.9% | 18.6% |
Scores
| Measure | Staar Surgical | Industry median |
|---|---|---|
| Graham Number | $3.39 | $34.37 |
| Graham Upside | -84.5% | -57.7% |
| Altman Z-Score | 7.09 | 1.95 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from Staar Surgical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.